Related references
Note: Only part of the references are listed.A randomized controlled phase III multicenter study on dose escalation in definitive chemoradiation for patients with locally advanced esophageal cancer: ARTDECO study.
Maarten C.C.M. Hulshof et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Comparing Paclitaxel Plus Fluorouracil Versus Cisplatin Plus Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Cancer: A Randomized, Multicenter, Phase III Clinical Trial
Yun Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
He-San Luo et al.
RADIATION ONCOLOGY (2019)
Cervical Esophageal Cancer Treatment Strategies: A Cohort Study Appraising the Debated Role of Surgery
Michele Valmasoni et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Long-term survival improvement in oesophageal cancer in the Netherlands
M. van Putten et al.
EUROPEAN JOURNAL OF CANCER (2018)
The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer
Paul M. Jeene et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2018)
Supraclavicular node disease is not an independent prognostic factor for survival of esophageal cancer patients treated with definitive chemoradiation
Paul M. Jeene et al.
ACTA ONCOLOGICA (2017)
A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS) (vol 26, pg 1547, 2015)
N. I. Cherny et al.
ANNALS OF ONCOLOGY (2017)
Integrated genomic characterization of oesophageal carcinoma
Jihun Kim et al.
NATURE (2017)
Outcome of proximal esophageal cancer after definitive combined chemo-radiation: a Swiss multicenter retrospective study
Evelyn Herrmann et al.
RADIATION ONCOLOGY (2017)
Dose escalation of definitive radiation is not associated with improved survival for cervical esophageal cancer: a National Cancer Data Base (NCDB) analysis
B. De et al.
DISEASES OF THE ESOPHAGUS (2017)
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review
Primoz Strojan et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)
Cervical esophageal cancer: a gap in cancer knowledge
A. Hoeben et al.
ANNALS OF ONCOLOGY (2016)
Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Lordick et al.
ANNALS OF ONCOLOGY (2016)
Multicenter Phase 2 Study of Cisplatin and 5-Fluorouracil With Concurrent Radiation Therapy as an Organ Preservation Approach in Patients With Squamous Cell Carcinoma of the Cervical Esophagus
Sadamoto Zenda et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Clinical efficacy and failure pattern in patients with cervical esophageal cancer treated with definitive chemoradiotherapy
Peng Zhang et al.
RADIOTHERAPY AND ONCOLOGY (2015)
Cervical esophageal cancer: A population-based study
G. Daniel Grass et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
A comparison of carboplatin and paclitaxel with cisplatinum and 5-fluorouracil in definitive chemoradiation in esophageal cancer patients
J. Honing et al.
ANNALS OF ONCOLOGY (2014)
Long-term results of definitive radiochemotherapy in locally advanced cancers of the cervical esophagus
E. Gkika et al.
DISEASES OF THE ESOPHAGUS (2014)
Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma
R. L. G. M. Blom et al.
DISEASES OF THE ESOPHAGUS (2014)
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
Thierry Conroy et al.
LANCET ONCOLOGY (2014)
Primary Radiotherapy Compared With Primary Surgery in Cervical Esophageal Cancer
Cai Neng Cao et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2014)
Chemoradiotherapy with or without cetuximab in patients with oesophageal cancer (SCOPE1): a multicentre, phase 2/3 randomised trial
Thomas Crosby et al.
LANCET ONCOLOGY (2013)
A tutorial on propensity score estimation for multiple treatments using generalized boosted models
Daniel F. McCaffrey et al.
STATISTICS IN MEDICINE (2013)
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
P. van Hagen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Are propensity scores really superior to standard multivariable analysis?
Giuseppe Biondi-Zoccai et al.
CONTEMPORARY CLINICAL TRIALS (2011)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients
Jean-Pierre Pignon et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival
Shao Hui Huang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781
Joel Tepper et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Concurrent chemoradiation for patients with squamous cell carcinoma of the cervical esophagus
T. Uno et al.
DISEASES OF THE ESOPHAGUS (2007)
Treatment results of radiotherapy for carcinoma of the cervical esophagus
Kazunari Yamada et al.
ACTA ONCOLOGICA (2006)
A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma
JL Lee et al.
ANNALS OF ONCOLOGY (2004)
Share Paper
